WILDTBVAC

Integrated solutions for Tuberculosis control in animals combining vaccination and multi-species diagnostics

Coordinatore	NEIKER-INSTITUTO VASCO DE INVESTIGACION Y DESARROLLO AGRARIO SA    more  Organization address address: BERREAGA KALEA 1 city: DERIO postcode: 48160 contact info Titolo: Ms. Nome: Yolanda Cognome: Fernandez Email: send email Telefono: +34 944 034 300 Fax: +34 944 034 310
Nazionalità Coordinatore	Spain [ES]
Totale costo	1˙560˙900 €
EC contributo	998˙204 €
Programma	FP7-KBBE Specific Programme "Cooperation": Food, Agriculture and Biotechnology
Code Call	FP7-KBBE-2013-7-single-stage
Funding Scheme	CP-TP
Anno di inizio	2013
Periodo (anno-mese-giorno)	2013-12-01   -   2015-11-30

 Partecipanti

#	participant	country	role	EC contrib. [€]
1	NEIKER-INSTITUTO VASCO DE INVESTIGACION Y DESARROLLO AGRARIO SA  Organization address address: BERREAGA KALEA 1 city: DERIO postcode: 48160 contact info Titolo: Ms. Nome: Yolanda Cognome: Fernandez Email: send email Telefono: +34 944 034 300 Fax: +34 944 034 310	ES (DERIO)	coordinator	131˙735.00
2	PRIONICS AG  Organization address address: WAGISTRASSE 27 A city: SCHLIEREN postcode: 8952 contact info Titolo: Dr. Nome: Alex Cognome: Raeber Email: send email Telefono: 41442002000 Fax: 41442002009	CH (SCHLIEREN)	participant	195˙800.00
3	INMUNOLOGIA Y GENETICA APLICADA SA  Organization address address: Hermanos Garcia Noblejas 41 city: MADRID postcode: 28037 contact info Titolo: Mr. Nome: Dominguez Cognome: Eduardo Email: send email Telefono: +34 913680501	ES (MADRID)	participant	160˙100.00
4	VACUNEK SL  Organization address address: BERREAGA KALEA 1 city: DERIO postcode: 48160 contact info Titolo: Ms. Nome: Beatriz Cognome: Lazaro Email: send email Telefono: +34 946573565	ES (DERIO)	participant	153˙160.00
5	UNIVERSIDAD DE CASTILLA - LA MANCHA  Organization address address: CALLE ALTAGRACIA 50 city: CIUDAD REAL postcode: 13071 contact info Titolo: Ms. Nome: Maria Llanos Cognome: Carrión Varela Email: send email Telefono: +34 967599354 Fax: +34 967599305	ES (CIUDAD REAL)	participant	101˙568.00
6	ISTITUTO SUPERIORE DI SANITA  Organization address address: Viale Regina Elena 299 city: ROMA postcode: 161 contact info Titolo: Dr. Nome: Rosa Maria Cognome: Martoccia Email: send email Telefono: +39 06 49902688 Fax: +39 06 49903007	IT (ROMA)	participant	94˙160.00
7	UNIVERSIDAD COMPLUTENSE DE MADRID  Organization address address: AVENIDA DE SENECA 2 city: MADRID postcode: 28040 contact info Titolo: Mrs. Nome: María Isabel Cognome: Rodríguez Villa Email: send email Telefono: 34913946376 Fax: 34913946382	ES (MADRID)	participant	88˙000.00
8	THE SECRETARY OF STATE FOR ENVIRONMENT, FOOD AND RURAL AFFAIRS  Organization address address: Area 1A, Nobel House, Smith Square 17 city: LONDON postcode: SW1P 3JR contact info Titolo: Mrs. Nome: Lucinda Cognome: Cranham Email: send email Telefono: +44 1932 359571 Fax: +44 1932 357230	UK (LONDON)	participant	73˙681.00

Mappa

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

 Obiettivo del progetto (Objective)

'Recent studies have showed estimations of worldwide 50 million cattle infections with M. bovis, at a cost to the agricultural community of 2-3 billion € per year. In developing countries, M. bovis infection is still widespread, in both cattle and humans. Even in developed countries, successful eradication of disease from livestock is hampered by the presence of wildlife reservoirs of M. bovis. Under these circumstances, a single case of a reportable disease in livestock can result in serious economic consequences for the producer, public, and governments. Within this scenario, there’s room and clear business opportunities for integrated control products or solutions that aim at addressing what is considered a global problem, animal tuberculosis. Our overall objective is therefore to take the results of the TB-STEP project - “Strategies for the eradication of bovine tuberculosis”, funded under FP7-KBBE-2007 with project number 212414, where most of the WildTBVac partners were involved, and build a pre-commercial set of TB control solutions by means of testing the technical and economical viability of the aforementioned integrated approach. WildTBVac specific objectives are the following: • To standardize and optimize the production of a TB Vaccine (prototype resulting of the TB-STEP project) • To evaluate several vaccine-compatible diagnostic strategies (also resulting from the TB-STEP project) that will include multi-species DIVA tests (wild boar, domestic pigs, cattle) • To assess the field efficacy of integrated TB control strategies including oral vaccination for TB control in wild boar • To evaluate the field efficacy of integrated TB control strategies including oral vaccination for TB control in domestic and feral pigs • To define the exploitation and commercialization strategy including clear technology transfer approaches and development of a market oriented business.'